Position in APGE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$836,464
+$584,361 QoQ
Shares Held
6,302
+88.7% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#184
of 281 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Quantbot Technologies LP holds $29,328,891 across 118 Biotechnology names. APGE ranks #7 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
80,193 | $4,496,421 | |
| 2 | TECH |
BIO-TECHNE Corp
|
52,802 | $3,730,461 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
5,724 | $1,071,990 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
17,880 | $975,175 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,460 | $910,368 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
10,831 | $882,834 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
This page
|
6,302 | $836,464 | |
| 8 | SYRE |
Spyre Therapeutics, Inc.
|
8,884 | $788,721 |
All Filings in APGE
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $836,464 | 6,302 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $252,103 | 3,340 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $95,630 | 2,407 | Shares | Sole | 2025-11-12 | |
| 2025-03-31 | $186 | 5 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||